1 French consensus procedure for assessing cognitive function in Parkinson’s disease Kathy Dujardin 1,2 *, Nicolas Auzou 3,4 , Eugénie Lhommée 5,6 , Virginie Czernecki 7 , Bruno Dubois 8 , Anne Fradet 9 , David Maltete 10,11 , Mylene Meyer 12 , Fanny Pineau 13 , Emmanuelle Schmitt 8,9 , François Sellal 13,14 , François Tison 3 , Tiphaine Vidal 15,16 , Jean-Philippe Azulay 17 , Marie-Laure Welter 18 , Jean-Christophe Corvol 19 , Franck Durif 15 , Olivier Rascol 20 on behalf of the NS-Park network 1 1 Univ. Lille, INSERM U1171 - Degenerative & vascular cognitive disorders, F-59000 Lille, France 2 CHU Lille, Neurology and movement disorders, F-59000 Lille, France 3 Institute of neurodegenerative disorders, CHU Bordeaux, F-33000 Bordeaux, France 4 Univ. Bordeaux, Psychology laboratory, EA4139, F-33000 Bordeaux, France 5 CHU Grenoble Alpes and Inserm U1216, F-38000 Grenoble, France 6 Univ. Grenoble Alpes, Grenoble Institut des Neurosciences, GIN, F-38000 Grenoble, France 7 CRICM UMRS 975, Neurology department, APHP, Salpetrière Hospital, F-75013 Paris, France 8 Université Pierre et Marie Curie, Paris VI, ICM, INSERM UMR_S975 and Dementia research center (IM2A), Salpêtrière Hospital, Paris, France 9 CHU Poitiers, Neurology & Neuropsychology, Expert Referent Center of Parkinson Disease, CMRR, F-86000 Poitiers, France 10 Department of Neurology, Rouen University Hospital, Rouen, France 11 INSERM U1073, Rouen Faculty of Medicine Rouen, France 12 CHU Nancy, Department of neurology, F-54000 Nancy, France 13 Département de Neurologie, Hôpitaux Civils de Colmar, F-68000, Colmar, France 14 INSERM U1118, Université de Strasbourg 15 CHU Clermont-Ferrand, Movement Disorders Centre, F-63000 Clermont-Ferrand, France 16 CHU Clermont-Ferrand, Resource and Research Memory Centre, F-63000 Clermont- Ferrand, France 17 Neurology and movement disorders, Hôpital de la Timone, AP-HM, Institut des neurosciences de la Timone, Université Aix-Marseille, F-13385 Marseille, France 18 INSERM UMRS-1127, F-75013, Paris, France 19 Sorbonne Universités, UPMC Univ Paris 06; INSERM UMRS-1127, CIC-1422; CNRS UMR-7225; and AP-HP; ICM, Hôpital Pitié-Salpêtrière, Département des maladies du système nerveux, F-75013, Paris, France 20 Clinical Investigation Center CIC1436 and Department of Clinical Pharmacolgy and Neurosciences, INSERM, Toulouse University Hospital and University of Toulouse, Toulouse, France *Corresponding Author: Kathy Dujardin, Neurologie et Pathologie du Mouvement, Neurologie A, Hôpital Salengro, Centre Hospitalier Universitaire, F-59037 Lille cedex, France Tel.: + 33 320 446 751 Fax: + 33 320 446 680 E-mail: kathy.dujardin@univ-lille2.fr 1 Members of the NS-Park network are listed in the acknowledgments. © 2016. This manuscript version is made available under the Elsevier user license http://www.elsevier.com/open-access/userlicense/1.0/